MicroRNA Profiling Implies New Markers of Gemcitabine Chemoresistance in Mutant p53 Pancreatic Ductal Adenocarcinoma

BACKGROUND: No reliable predictors of susceptibility to gemcitabine chemotherapy exist in pancreatic ductal adenocarcinoma (PDAC). MicroRNAs (miR) are epigenetic gene regulators with tumorsuppressive or oncogenic roles in various carcinomas. This study assesses chemoresistant PDAC for its specific m...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:PLoS One
Autores principales: Dhayat, Sameer A., Mardin, Wolf Arif, Seggewiß, Jochen, Ströse, Anda Jana, Matuszcak, Christiane, Hummel, Richard, Senninger, Norbert, Mees, Sören Torge, Haier, Jörg
Formato: Artigo
Lenguaje:Inglês
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4659591/
https://ncbi.nlm.nih.gov/pubmed/26606261
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0143755
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares